Sen-Jam Pharmaceutical

Impacting billions by elegantly modulating inflammation at the source, preserving health span

Last Funded April 2025

$3,372,893

raised from 1,495 investors
Pitch Video
Investor Panel

Investor Panel

Play Video

What Investors Say

LEAD INVESTOR
Invested $130,000 this round + $135,000 previously
Sen-Jam's therapeutic approach could potentially revolutionize the cost effective treatment of significant maladies that affect millions of people. The company brings together three core investment priorities for me: 1) finding early stage companies with significant upside potential: 2) leveraging the talents of experienced entrepreneurial management; 3) making a meaningful difference in the world. Since my first investment in Sen-Jam, I've been impressed by how much they've accomplished with limited resources, and by the commitment and excellent communication of the founders. It has instilled enough confidence for me to increase my investment by over 20% this time.
What People Say